Access cutting-edge platinum-sensitive ovarian cancer treatment through this phase 3 clinical trial at a research site in Tigard. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tigard location
Preparing your pre-screening questions…
Access platinum-sensitive ovarian cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related platinum-sensitive ovarian cancer treatment provided free
Check if you qualify for this platinum-sensitive ovarian cancer clinical trial in Tigard, OR
No-Cost Study Care
Local to Tigard
Convenient for OR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This Phase 3 study will be conducted in different countries around the world with up to about 688 participants. The purpose of this study is to evaluate how well Rina-S works against ovarian cancer in combination with or without bevacizumab and how it compares to an investigator's choice of platinum-based chemotherapy with or without bevacizumab. Participants will receive either: * Rina-S monotherapy (by itself), * Rina-S plus bevacizumab, * investigator's choice chemotherapy (by itself) (standard of care), or * investigator's choice chemotherapy plus bevacizumab (standard of care). No participants will be given placebo. Participants will participate in 1 of 2 arms. The treatment duration will be different for every participant. If a participant's cancer stays the same or gets better, and there are not any serious problems, participants can keep getting study treatment for as long as the study is open. Participants will be asked to attend 1 to 3 visits at the study clinic for each cycle (duration of cycle is 3 or 4 weeks, depending on medication received). During visits, there will be various tests (such as blood draws) and procedures (such as recording of heart activity and imaging) to monitor whether the study treatment is safe and effective. The overall study duration (including screening, treatment, and follow-up) will be different for every participant.
Sponsor: Genmab
Yes, this clinical trial (NCT07564141) has an active research site in Tigard, OR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for platinum-sensitive ovarian cancer treatment options in Tigard, OR, this clinical trial (NCT07564141) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tigard research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced platinum-sensitive ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all platinum-sensitive ovarian cancer clinical trials near you to find additional studies recruiting in your area.
See all ovarian cancer clinical trials recruiting in Tigard — not just this study.
Browse Ovarian Cancer Trials in Tigard →